<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName bmc2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Thyroid Res</journal-id><journal-title-group><journal-title>Thyroid Research</journal-title></journal-title-group><issn pub-type="epub">1756-6614</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3155109</article-id><article-id pub-id-type="publisher-id">1756-6614-4-S1-S3</article-id><article-id pub-id-type="pmid">21835050</article-id><article-id pub-id-type="doi">10.1186/1756-6614-4-S1-S3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Hypothyroidism and mood disorders: integrating novel insights from brain imaging techniques</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Pilhatsch</surname><given-names>Maximilian</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Marxen</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Winter</surname><given-names>Christine</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Smolka</surname><given-names>Michael N </given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" corresp="yes" id="A5"><name><surname>Bauer</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>michael.bauer@uniklinikum-dresden.de</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universit&#x000e4;t Dresden, Dresden, Germany</aff><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>3</day><month>8</month><year>2011</year></pub-date><volume>4</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">New aspects of thyroid hormone synthesis and action</named-content><named-content content-type="supplement-editor">Heike Biebermann</named-content></supplement><fpage>S3</fpage><lpage>S3</lpage><permissions><copyright-statement>Copyright &#x000a9;2011 Pilhatsch et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2011</copyright-year><copyright-holder>Pilhatsch et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.thyroidresearchjournal.com/content/4/S1/S3"/><abstract><sec><title>Abstract</title><p>Thyroid hormones play a critical role in brain development but also in the adult human brain by modulating metabolic activity. Hypothyroid states are associated with both functional and structural brain alterations also seen in patients with major depression. Recent animal experimental and preclinical data indicate subtle changes in myelination, microvascular density, local neurogenesis, and functional networks. The translational validity of such studies is obviously limited. Clinical evidence for neurobiological correlates of different stages and severities of hypothyroidism and effects of pharmacological intervention is lacking but may be achieved using advanced imaging techniques, e.g. functional and quantitative MRI techniques applied to patients with hypothyroidism before and after hormone replacement therapy.</p></sec></abstract></article-meta></front><body><sec><title>Introduction</title><p>The profound influence of thyroid hormones on brain development in humans has been studied extensively [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. Hypothyroidism is a clinical condition which is either characterized only by elevated levels of the thyroid stimulating hormone (TSH; &#x0201c;subclinical hypothyroidism&#x0201d;) or additional low levels of trijodothyronine (T3) and thyroxin (T4) respectively (overt hypothyroidism). Taken together overt (0.4%) and subclinical (9%) hypothyroisism is prevalent in about 9.4 % of the adult population [<xref ref-type="bibr" rid="B7">7</xref>] and commonly affects brain function. Conversely, 15% of patients with depression display hypothyroid states including subclinical hypothyroidism [<xref ref-type="bibr" rid="B8">8</xref>], and about 25-30% of depressed patients show a pathological response to the thyreotropine releasing hormone (TRH) stimulation test [<xref ref-type="bibr" rid="B9">9</xref>].</p><p>The concepts of thyroid hormone action in the adult brain have changed dramatically along with rapid advances in basic science and methodological techniques over the past decades [<xref ref-type="bibr" rid="B10">10</xref>]. Particularly brain imaging techniques evaluating cerebral metabolism, perfusion, and anatomy enabled encouraging insights into the thyroid-brain relationship. As a result, it is now widely accepted that thyroid hormones play a critical role in the adult brain impacting mood and cognition. Even if crucial details of the underlying mechanisms still remain unknown [<xref ref-type="bibr" rid="B11">11</xref>], the therapeutic use of thyroid hormones in the clinical treatment of mood disorders has already been established in predominantly open trials with sometimes limited numbers of patients.</p><p>Thyroid hormone treatment has been shown to accelerate and augment antidepressant pharmacotherapy and to support maintenance therapy of bipolar affective disorders, even in patients with euthyroid hormonal state [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. Specifically, there is good evidence that trijodthyronine (T<sub>3</sub>) can accelerate [<xref ref-type="bibr" rid="B13">13</xref>] and augment [<xref ref-type="bibr" rid="B14">14</xref>] the therapeutic response to tricyclic antidepressants and selective serotonin reuptake inhibitors (SSRIs) in depression.</p><p>Adjunctive treatment with supraphysiological doses of Levothyroxine (T<sub>4</sub>) was found to be effective in open clinical studies of patients with affective disorders [<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B18">18</xref>]. In a subset of 21 patients with treatment-resistant affective disorder, very high doses of up to 600 &#x003bc;g per day L-T<sub>4</sub> were required to achieve therapeutic response with a good tolerability even over mean treatment periods of up to 51 month [<xref ref-type="bibr" rid="B16">16</xref>].</p><p>In the first double-blind randomized placebo-controlled trial (RCT) to evaluate efficacy and tolerability of supraphysiological doses of L-T4 in 63 patients, we found that bipolar depressed women treated with L-T4 showed a better improvement in depression scores than those treated with placebo. However including both genders, the study failed to detect an overall statistically significant treatment effect (Stamm et al., in preparation).</p></sec><sec><title>Brain imaging methods</title><p>Principal brain imaging techniques mentioned in this article are single photon emission computed tomography (SPECT), positron emission tomography (PET), and different methods of magnetic resonance imaging (MRI). PET and SPECT are nuclear imaging methods that require the injection of radioactive tracers into the circulatory system. Those tracers bind to molecular structures like transporters and receptors in the human brain. Measuring of the local distribution of the bound tracers allows an estimation of regional brain activation or availability of receptors. The glucose analog [<sup>18</sup>F]-Fluor-2-Desoxy-D-Glucose (FDG) is by far the most commonly used PET tracer and its metabolism reflects the amount of brain activity in different brain regions.</p><p>In contrast to these nuclear imaging methods, MRI is non-invasive and uses magnetic fields and radio waves instead of ionizing radiation. Structural MRI methods allow creating images of anatomical structures in an excellent spatial resolution (less than 1 mm). Diffusion tensor imaging (DTI) characterizes the mobility of water molecules and, thus, the directionality and integrity of white matter tracts. Magnetization transfer (MT) is sensitive to myelin content and is therefore useful in detecting early demyelination processes.</p><p>Functional magnetic resonance imaging (fMRI) has become the tool of choice to study functional aspects of the human brain. This method detects local increases of blood flow and the following decrease of deoxygenated hemoglobin during task related brain activity. The signal measured directly relies on the so-called BOLD (blood oxygen level dependent) effect. It is based on the different magnetic properties of oxygenated and deoxygenated hemoglobin. The origin of the BOLD signal is still a matter of discussion as it is also based on the complex interaction of neuronal metabolism, neuronal activity, blood flow and blood volume. Nevertheless fMRI enables the monitoring of active neuronal networks during the performance of specific paradigms, e.g. a memory task. Related to affective disorders, MRI allows the investigation of functional and structural deficits associated with neuropsychiatric symptoms as well as treatment effects.</p><p>Major advantages of neuroimaging methods are that brain structure and function as well as molecular and neurochemical processes can be studied in the living human. An important limitation of the mentioned brain imaging techniques refers to temporal resolution. While neuronal activities occur in the range of milliseconds, processes detected by imaging methods currently ranges between seconds (fMRI) and minutes (PET). Additionally, all methods measure brain activity indirectly through changes in blood flow or glucose uptake. Consequently, alterations in baseline perfusion and metabolic rate of oxygen may affect the results. Moreover it is currently not possible to reliably distinguish between inhibitory and excitatory neuronal activities. Nevertheless, given the rapid developments in neuroimaging methods; many limitations may hopefully be overcome in the next decades [<xref ref-type="bibr" rid="B19">19</xref>].</p></sec><sec><title>Mechanisms of action</title><p>On the molecular level, thyroid hormones act via genomic and non-genomic effects. As part of the nuclear superfamily of ligand-modulated transcription factors, thyroid hormones bind to intracellular nuclear receptors [<xref ref-type="bibr" rid="B20">20</xref>]. Genomic actions of T<sub>3</sub> are mediated through the control and usually increase of gene expression [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. Genes that are regulated by thyroid hormones are known to encode for proteins such as myelin, neurotrophins, and proteins that are involved in intracellular signaling pathways [<xref ref-type="bibr" rid="B23">23</xref>].</p><p>Non-genomic actions of thyroid hormones have been described in the brain and peripheral tissues. After binding to cytoplasmic thyroid hormone receptors, T<sub>3</sub> appears to be able to rapidly activate the phosphatidylinositol-3-kinase protein pathway and thereby achieves vasodilatory and neuroprotective effects [<xref ref-type="bibr" rid="B24">24</xref>]. Additionally, an increase in serotonergic neurotransmission is mediated by a thyroid hormone induced reduction of the sensitivity of 5-HT1A autoreceptors in the raphe nuclei and increase in 5-HT2 receptor sensitivity [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. The exact role of these non-genomic signaling mechanisms, their regulation, and interaction with the slower genomic pathways remains to be elucidated.</p><p>Thyroid hormone homeostasis in the brain underlies a complex interaction of different autoregulative mechanisms [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>]. The activity of specific thyroid hormone transporters (MCT8, LAT2) and the carrier transthyretin determines intracellular concentration of thyroid hormones via mediating their cellular influx and efflux under consideration of overall circulating levels of T<sub>4</sub> and T<sub>3</sub>[<xref ref-type="bibr" rid="B27">27</xref>]<sub>.</sub> The activity of deiodinases [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>] controls local bioavailability of T3 in concert with other less understood mechanisms, e.g. the local distribution of the different nuclear thyroid hormone receptors (TR&#x003b1; and TR&#x003b2; in diverse isoforms) [<xref ref-type="bibr" rid="B31">31</xref>]. Thyroid hormone receptors are widely distributed in the brain with highest concentrations in cerebral cortex, hippocampus, amygdala, plexus choroideus and olfactory bulb [<xref ref-type="bibr" rid="B31">31</xref>].</p><p>Interestingly, the limbic structures, where thyroid hormone receptors are prevalent, have repeatedly been shown to be implicated in the pathogenesis of mood disorders [<xref ref-type="bibr" rid="B32">32</xref>]. However, the neuropharmacological basis and the functional pathways for the modulatory effects of thyroid hormones on mood are yet to be understood, even though several studies revealed interactions with different neurotransmitter systems, which are generally believed to play a major role in the regulation of mood and behaviour, i.e norepinephrine or serotonine [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B33">33</xref>].</p></sec><sec><title>Structural changes induced by hypothyroidism</title><p>Thyroid hormones are known to affect neuronal differentiation, migration, myelination, synaptogenesis, and dendritic branching [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>]. Therefore, hypothyroidism will change brain structure and the changes will depend on the onset time of the condition. Hypothyroid rodents display a loss of neurons in several brain regions. Next to the visual cortex [<xref ref-type="bibr" rid="B36">36</xref>] and cerebellum [<xref ref-type="bibr" rid="B37">37</xref>], the hippocampal formations were studied repeatedly. The number of granule cells in the dentate gyrus was reduced [<xref ref-type="bibr" rid="B38">38</xref>] with a more severe effect of hypothyroidism during development than during adulthood [<xref ref-type="bibr" rid="B39">39</xref>]. Rats treated with methimazole, a hypothyroidism inducing drug, showed a reduced count of pyramidal neurons in the CA3 hippocampal region [<xref ref-type="bibr" rid="B40">40</xref>]. This was found even if methimazole was administered in adulthood. Animals could be fully protected with T4 replacement and partially protected with T3 replacement [<xref ref-type="bibr" rid="B41">41</xref>]. It is speculated that this protective potency is mediated through the activation of hippocampal progenitor cells of the supraventricular zone and the dentate gyrus [<xref ref-type="bibr" rid="B42">42</xref>]. Mice with a heterozygous mutation of the thyroid hormone receptor alpha 1 showed a reduced density of GABAergic inhibitory interneurons in the CA1 hippocampal region [<xref ref-type="bibr" rid="B40">40</xref>]. On the behavioural side, these mice show increases in markers for depression and anxiety [<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B44">44</xref>]. Both the behavioural measures as well as the neuronal density normalized with high levels of T3 administered in adulthood. In contrast to the above findings, hypothyroid rats treated at age 0-30 days with propylthiouracil (PTU) showed a loss of pyramidal neurons in CA1, which did not ameliorate after withdrawal of the drug and approximate normalization of serum T4 levels [<xref ref-type="bibr" rid="B45">45</xref>]. A thyroidectomy at day 30 also reduced the number of neurons. The same study reported in CA3 a volume decrease of the pyramidal layer combined with an increase in neuronal density and no loss in the total number of pyramidal neurons. Only one study is known in this context that applied MRI in rodents [<xref ref-type="bibr" rid="B46">46</xref>]. Using manual segmentation, perinatal hypothyroidism induced with methimazole administered to mother rats was found to reduced total brain size of the litter but not the relative size of the hippocampus.</p><p>Effects of T3 and T4 have also been reported in the process of myelination or remyelination in mice [<xref ref-type="bibr" rid="B47">47</xref>,<xref ref-type="bibr" rid="B48">48</xref>] and rats [<xref ref-type="bibr" rid="B49">49</xref>,<xref ref-type="bibr" rid="B50">50</xref>]. Harsan et al. [<xref ref-type="bibr" rid="B48">48</xref>] used Diffusion Tensor Imaging (DTI) in combination with histology to serve as a marker for remyelination in mice and found that cuprizone induced demyelination in adulthood was reversable through treatment with T3, which increased the number of oligodendrocyte progenitor cells. Using histology and electronmicroscopy, Franklin and Gilson [<xref ref-type="bibr" rid="B51">51</xref>] found that Schwann cell remyelination was decreased in thyroidectomized rats but not oligodendrocyte remyelination.</p><p>While the efficacy of thyroid hormone treatments is generally accepted, human data on structural changes in the brain is sparse. Using proton MRS, Jagannathan et al. [<xref ref-type="bibr" rid="B52">52</xref>] found that abnormalities related to myelin maturation were reversible under T4 therapy in three mentally disabled patients with congential hypothyroidism. A more recent investigation [<xref ref-type="bibr" rid="B53">53</xref>] using similar MRS and MRI methodology demonstrated general atrophy and signs of demyelination in two children with monocarboxylate transporter 8 (MCT8) gene deficiency, which is associated with a syndrome combining thyroid and severe neurological abnormalities.</p><p>Systematic group studies of structural brain changes due to hypothyroidism and thyroid hormone therapy are needed both during development and in adulthood. In addition to MRS, recent advances in structural MRI, quantitative MRI, and image analysis techniques could be utilized to test hypotheses derived from animal studies in human. Structural changes related to myelin can now be studied with quantitative T2 or quantitative magnetization transfer (MT) imaging [<xref ref-type="bibr" rid="B54">54</xref>]. Diffusion tensor imaging (DTI) can reveal information on white matter integrity. Changes in grey matter density [<xref ref-type="bibr" rid="B55">55</xref>] or cortical thickness [<xref ref-type="bibr" rid="B56">56</xref>,<xref ref-type="bibr" rid="B57">57</xref>] can be studied with T1-weighted images.</p></sec><sec><title>Vascular Changes and Perfusion</title><p>Thyroid hormones are known to affect the vascular system. Hypothyroidism is associated with impaired fibrinolysis and blood coagulation resulting in cerebrovascular diseases [<xref ref-type="bibr" rid="B58">58</xref>]. It also compromises protective endothelial [<xref ref-type="bibr" rid="B59">59</xref>] and thrombocyte functions as well as lipid metabolism [<xref ref-type="bibr" rid="B60">60</xref>].</p><p>In the rat forebrain, a significant reduction in blood vessel density was observed in untreated rats thyroidectomised shortly after birth compared to euthyroid control animals and thyroidectomized rats treated with T4 or the thyroid hormone analog 3,5-diiothyroprionic acid (DITPA) [<xref ref-type="bibr" rid="B61">61</xref>]. Treatment induced angiogenesis and improved functioning of endothelial cells with secondary impact on local oxygen consumption and metabolic activity.</p><p>PET and SPECT measurements of cerebral blood flow under consideration of the thyroid system revealed partially conflicting results. Most consistently hypothyroidism was associated with global, diffuse hypoperfusion [<xref ref-type="bibr" rid="B62">62</xref>,<xref ref-type="bibr" rid="B63">63</xref>]. Several studies pointed to more regional effects including perfusion deficits pronounced in posterior brain regions [<xref ref-type="bibr" rid="B64">64</xref>-<xref ref-type="bibr" rid="B66">66</xref>] or in the parietal lobe [<xref ref-type="bibr" rid="B63">63</xref>].</p><p>Interpretation of the findings regarding reversibility of perfusion abnormalities under treatment is especially challenging. Whereas several studies report partial normalization of perfusion [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B62">62</xref>,<xref ref-type="bibr" rid="B67">67</xref>], others demonstrate [<xref ref-type="bibr" rid="B64">64</xref>-<xref ref-type="bibr" rid="B66">66</xref>] ongoing regional hypoperfusion under hormone replacement therapy. In contrast to the hypoperfusion pattern reported for hypothyroidism by Kraus et al. [<xref ref-type="bibr" rid="B64">64</xref>] in otherwise healthy subjects with posterior hypoperfusion and slight hyperperfusion anteriorly, depressed patients showed hypoperfusion in limbic, subcortical and frontal brain regions [<xref ref-type="bibr" rid="B32">32</xref>], which normalized under therapy with supraphysiological dosages (300 mcg/day) of T<sub>4</sub>.</p><p>Differences in the studied populations may be the reason for such variable findings. Published results refer either to severe cases of hypothyroidism [<xref ref-type="bibr" rid="B62">62</xref>,<xref ref-type="bibr" rid="B63">63</xref>] or mild cases [<xref ref-type="bibr" rid="B66">66</xref>,<xref ref-type="bibr" rid="B68">68</xref>]. Some studies excluded patients with co-morbid psychiatric diseases like depression [<xref ref-type="bibr" rid="B64">64</xref>,<xref ref-type="bibr" rid="B68">68</xref>], while other studies included also depressed patients [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B69">69</xref>]. In addition, the duration of the disease was variable. Only one study examined populations with varying severity and duration of the disease [<xref ref-type="bibr" rid="B17">17</xref>]. Taken together the existing data may indicate that long and severe hypothyroidism, presumably leading to irreversible structural neuronal and vascular changes, is associated with chronic perfusion and functional alterations, which may be ameliorated by treatment but not fully restored. In contrast, shorter and milder courses of hypothyroidism, presumably not being paralleled by irreversible structural changes, seem to be more accessible to substitution treatment.</p></sec><sec><title>Glucose metabolism</title><p>In line with findings that general glucose metabolism is tightly coupled to perfusion [<xref ref-type="bibr" rid="B3">3</xref>], preclinical studies generally reported alterations of glucose metabolism in hypothyroid conditions [<xref ref-type="bibr" rid="B63">63</xref>,<xref ref-type="bibr" rid="B69">69</xref>]. More specifically, Bauer et al. related depressive symptoms in hypothyroidism to regionally decreased glucose metabolism, particularly in the peri-genual anterior cingulate cortex region and the hippocampus [<xref ref-type="bibr" rid="B17">17</xref>] in a glucose-PET study. After 3 months of T4 substitution therapy, activity patterns normalized. Circulating TSH levels before initiation of therapy showed a significant positive correlation with glucose metabolism in the right ACC and negative correlations in the hippocampus. Interestingly, these two regions express TSH receptors very densely according to topographic studies in rat and human [<xref ref-type="bibr" rid="B70">70</xref>], whereby suggesting a direct and relevant effect of elevated TSH levels on the limbic system is of course highly speculative.</p></sec><sec><title>Cognitive and emotional functional changes</title><p>In line with the wide range of metabolic, perfusional and structural implications of the thyroid system, the literature on functional alterations related to thyroid diseases is large. Disturbances of the thyroid system, particularly if leading to a hypothyroid state, may profoundly alter mental functions influencing cognition and emotions. Severe hypothyroidism may lead to both severe depression and dementia [<xref ref-type="bibr" rid="B71">71</xref>] especially if left untreated [<xref ref-type="bibr" rid="B72">72</xref>].</p><p>Neuropsychologically, several cognitive defects in general intelligence, psychomotor speed, visual-spatial skills, working and long-term memory have been observed ranging from minimal to severe [<xref ref-type="bibr" rid="B73">73</xref>-<xref ref-type="bibr" rid="B75">75</xref>]. It was suggested that hypothyroid-related memory defects are not attributable to an attention deficit but rather to specific retrieval deficits [<xref ref-type="bibr" rid="B73">73</xref>,<xref ref-type="bibr" rid="B76">76</xref>]. Motor skills, language, inhibitory efficiency, and sustained attention appear to be less impacted by hypothyroidism [<xref ref-type="bibr" rid="B73">73</xref>,<xref ref-type="bibr" rid="B75">75</xref>]. Older adults were more vulnerable to cognitive changes due to hypothyroidism [<xref ref-type="bibr" rid="B75">75</xref>].</p><p>It is still a matter of discussion as to whether subclinical hypothyroidism is associated with cognitive impairments. In some studies, patients with subclinical hypothyroidism performed worse than controls on well established neuropsychological tests such as the Wechsler Adult Intelligence Scale or the Wechsler Memory scale [<xref ref-type="bibr" rid="B77">77</xref>,<xref ref-type="bibr" rid="B78">78</xref>], while other studies found no association between subclinical hypothyroidism and several aspects of cognition [<xref ref-type="bibr" rid="B75">75</xref>,<xref ref-type="bibr" rid="B79">79</xref>,<xref ref-type="bibr" rid="B80">80</xref>]. A consistent finding among many studies was a specific deficit in working memory tasks [<xref ref-type="bibr" rid="B73">73</xref>]. These neuropsychological findings were additionally underlined by a functional MRI (fMRI) study by Zhu et al. [<xref ref-type="bibr" rid="B68">68</xref>] who found that working memory was impaired in patients with subclinical hypothyroidism but not other memory functions. These impairments were reversible with l-thyroxine (L-T<sub>4</sub>) treatment.</p><p>Despite clinical evidence of an increased vulnerability for affective disorders coming along with hypothyroid states, neurobiological correlates of this disposition are not systematically investigated yet. This is of particular interest because a study by Maheu et al. [<xref ref-type="bibr" rid="B81">81</xref>] demonstrated that fMRI could detect greater hippocampal and amygdala activation in 12 non-depressed adolescent patients with Cushing's syndrome, when encoding affective stimuli (i.e. emotional faces) compared to 22 healthy controls. A similar pattern of brain activation has previously been demonstrated in adolescents suffering from manifest depression in an equivalent paradigm [<xref ref-type="bibr" rid="B82">82</xref>]. Cushing&#x000c2;&#x000b4;s syndrome is defined by hypercortisolemia and highly associated with prevalence of depressive symptoms in adults [<xref ref-type="bibr" rid="B83">83</xref>] and shows in this respect distinct parallels to hypothyroidism.</p></sec><sec><title>Conclusions</title><p>Hypothyroid states have a multitude of effects on structure, perfusion and function of the central nervous system. Recent research aims to combine modern brain imaging techniques with years of experience in neuropsychological and clinical evaluations of thyroid dysfunctions. The results are encouraging, and the description of the interactions between thyroid and affective disorders is taking on a new dimension. Nonetheless, the potential of modern techniques has hardly been exhausted. For example, non invasive measurements of brain perfusion like arterial-spin-labeling (ASL) &#x02013; already established in characterisation of different cerebrovascular diseases [<xref ref-type="bibr" rid="B84">84</xref>] &#x02013; would be suitable for transferring hypotheses about the influence of angiogenesis [<xref ref-type="bibr" rid="B85">85</xref>] from animal models into humans. fMRI in patients with thyroid diseases of different length and severity could help to identify functional aberrations such as memory impairments or altered emotional processing, which has long been suggested from animal studies. Structural changes related to myelin, which have been observed in various animal models, can now be studied with quantitative T2 or quantitative magnetization transfer (MT) imaging [<xref ref-type="bibr" rid="B86">86</xref>]. Finally diffusion tensor imaging (DTI) [<xref ref-type="bibr" rid="B54">54</xref>] can reveal information on white matter integrity.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>MP participated in the design and the preparation of the manuscript. MM participated in the preparation and revision of the manuscript. MNS, CW and MB participated in its design, revisions and coordination. All authors read and approved the final manuscript.</p></sec></body><back><sec><title>Acknowledgements</title><p>This article has been published as part of <italic>Thyroid Research</italic> Volume 4 Supplement 1, 2011: New aspects of thyroid hormone synthesis and action. The full contents of the supplement are available online at <ext-link ext-link-type="uri" xlink:href="http://www.thyroidresearchjournal.com/supplements/4/S1">http://www.thyroidresearchjournal.com/supplements/4/S1</ext-link></p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Bernal</surname><given-names>J</given-names></name><name><surname>Nunez</surname><given-names>J</given-names></name><name><surname>Gjessing</surname><given-names>R</given-names></name><article-title>Thyroid-Hormones and Brain-Development</article-title><source>European Journal of Endocrinology</source><year>1995</year><volume>133</volume><fpage>390</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1530/eje.0.1330390</pub-id><pub-id pub-id-type="pmid">7581959</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Ahmed</surname><given-names>OM</given-names></name><name><surname>El Gareib</surname><given-names>AW</given-names></name><name><surname>El Bakry</surname><given-names>AM</given-names></name><name><surname>Abd El-Tawab</surname><given-names>SM</given-names></name><name><surname>Ahmed</surname><given-names>RG</given-names></name><article-title>Thyroid hormones states and brain development interactions</article-title><source>Int J Dev Neurosci</source><year>2008</year><volume>26</volume><fpage>147</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1016/j.ijdevneu.2007.09.011</pub-id><pub-id pub-id-type="pmid">18031969</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Gur</surname><given-names>RC</given-names></name><name><surname>Ragland</surname><given-names>JD</given-names></name><name><surname>Reivich</surname><given-names>M</given-names></name><name><surname>Greenberg</surname><given-names>JH</given-names></name><name><surname>Alavi</surname><given-names>A</given-names></name><name><surname>Gur</surname><given-names>RE</given-names></name><article-title>Regional Differences in the Coupling between Resting Cerebral Blood Flow and Metabolism may Indicate Action Preparedness as a Default State</article-title><source>Cerebral Cortex</source><year>2009</year><volume>19</volume><fpage>375</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">18534991</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Horn</surname><given-names>S</given-names></name><name><surname>Heuer</surname><given-names>H</given-names></name><article-title>Thyroid hormone action during brain development: more questions than answers</article-title><source>Mol Cell Endocrinol</source><year>2010</year><volume>315</volume><fpage>19</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2009.09.008</pub-id><pub-id pub-id-type="pmid">19765631</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Koibuchi</surname><given-names>N</given-names></name><name><surname>Chin</surname><given-names>WW</given-names></name><article-title>Thyroid hormone action and brain development</article-title><source>Trends Endocrinol Metab</source><year>2000</year><volume>11</volume><fpage>123</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1016/S1043-2760(00)00238-1</pub-id><pub-id pub-id-type="pmid">10754532</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Koibuchi</surname><given-names>N</given-names></name><article-title>Effects of thyroid hormone on function and development of the brain</article-title><source>Nippon Rinsho</source><year>2005</year><volume>63</volume><issue>Suppl 10</issue><fpage>78</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">16279607</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Canaris</surname><given-names>GJ</given-names></name><name><surname>Manowitz</surname><given-names>NR</given-names></name><name><surname>Mayor</surname><given-names>G</given-names></name><name><surname>Ridgwa</surname><given-names>EC</given-names></name><article-title>The Colorado thyroid disease prevalence study</article-title><source>Arch Intern Med</source><year>2000</year><volume>160</volume><issue>4</issue><fpage>526</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1001/archinte.160.4.526</pub-id><pub-id pub-id-type="pmid">10695693</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Gold</surname><given-names>MS</given-names></name><name><surname>Pottash</surname><given-names>ALC</given-names></name><name><surname>Extein</surname><given-names>I</given-names></name><article-title>Hypothyroidism and Depression - Evidence from Complete Thyroid-Function Evaluation</article-title><source>JAMA</source><year>1981</year><volume>245</volume><issue>19</issue><fpage>1919</fpage><lpage>1922</lpage><pub-id pub-id-type="doi">10.1001/jama.245.19.1919</pub-id><pub-id pub-id-type="pmid">7230383</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Loosen</surname><given-names>PT</given-names></name><article-title>The Trh-Induced Tsh Response in Psychiatric-Patients - A Possible Neuro-Endocrine Marker</article-title><source>Psychoneuroendocrinology</source><year>1985</year><volume>10</volume><fpage>237</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1016/0306-4530(85)90002-2</pub-id><pub-id pub-id-type="pmid">2865765</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Oppenheimer</surname><given-names>JH</given-names></name><article-title>Evolving concepts of thyroid hormone action</article-title><source>Biochimie</source><year>1999</year><volume>81</volume><fpage>539</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1016/S0300-9084(99)80107-2</pub-id><pub-id pub-id-type="pmid">10403187</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Goetz</surname><given-names>T</given-names></name><name><surname>Glenn</surname><given-names>T</given-names></name><name><surname>Whybrow</surname><given-names>PC</given-names></name><name><surname>Gjessing</surname><given-names>R</given-names></name><article-title>The thyroid-brain interaction in thyroid disorders and mood disorders</article-title><source>Journal of Neuroendocrinology</source><year>2008</year><volume>20</volume><fpage>1101</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2826.2008.01774.x</pub-id><pub-id pub-id-type="pmid">18673409</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Bernal</surname><given-names>J</given-names></name><article-title>Action of thyroid hormone in brain</article-title><source>Journal of Endocrinological Investigation</source><year>2002</year><volume>25</volume><fpage>268</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">11936472</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Aronson</surname><given-names>R</given-names></name><name><surname>Offman</surname><given-names>HJ</given-names></name><name><surname>Joffe</surname><given-names>RT</given-names></name><name><surname>Naylor</surname><given-names>CD</given-names></name><article-title>Triiodothyronine augmentation in the treatment of refractory depression - A meta-analysis</article-title><source>Archives of General Psychiatry</source><year>1996</year><volume>53</volume><fpage>842</fpage><lpage>848</lpage><pub-id pub-id-type="pmid">8792761</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Cooper-Kazaz</surname><given-names>R</given-names></name><name><surname>Apter</surname><given-names>JT</given-names></name><name><surname>Cohen</surname><given-names>R</given-names></name><name><surname>Karagichev</surname><given-names>L</given-names></name><name><surname>Muhammed-Moussa</surname><given-names>S</given-names></name><name><surname>Grupper</surname><given-names>D</given-names></name><name><surname>Drori</surname><given-names>T</given-names></name><name><surname>Newman</surname><given-names>ME</given-names></name><name><surname>Sackeim</surname><given-names>HA</given-names></name><name><surname>Glaser</surname><given-names>B</given-names></name><etal/><article-title>Combined treatment with sertraline and liothyronine in major depression - A randomized, double-blind, placebo-controlled trial</article-title><source>Archives of General Psychiatry</source><year>2007</year><volume>64</volume><fpage>679</fpage><lpage>688</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.64.6.679</pub-id><pub-id pub-id-type="pmid">17548749</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Hellweg</surname><given-names>R</given-names></name><name><surname>Graf</surname><given-names>KJ</given-names></name><name><surname>Baumgartner</surname><given-names>A</given-names></name><article-title>Treatment of refractory depression with high-dose thyroxine</article-title><source>Neuropsychopharmacology</source><year>1998</year><volume>18</volume><fpage>444</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1016/S0893-133X(97)00181-4</pub-id><pub-id pub-id-type="pmid">9571653</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Berghofer</surname><given-names>A</given-names></name><name><surname>Bschor</surname><given-names>T</given-names></name><name><surname>Baumgartner</surname><given-names>A</given-names></name><name><surname>Kiesslinger</surname><given-names>U</given-names></name><name><surname>Hellweg</surname><given-names>R</given-names></name><name><surname>Adli</surname><given-names>M</given-names></name><name><surname>Baethge</surname><given-names>C</given-names></name><name><surname>Muller-Oerlinghausen</surname><given-names>B</given-names></name><article-title>Supraphysiological doses of L-thyroxine in the maintenance treatment of prophylaxis-resistant affective disorders</article-title><source>Neuropsychopharmacology</source><year>2002</year><volume>27</volume><fpage>620</fpage><lpage>628</lpage><pub-id pub-id-type="pmid">12377398</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Silverman</surname><given-names>DH</given-names></name><name><surname>Schlagenhauf</surname><given-names>F</given-names></name><name><surname>London</surname><given-names>ED</given-names></name><name><surname>Geist</surname><given-names>CL</given-names></name><name><surname>Van Herle</surname><given-names>K</given-names></name><name><surname>Rasgon</surname><given-names>N</given-names></name><name><surname>Martinez</surname><given-names>D</given-names></name><name><surname>Miller</surname><given-names>K</given-names></name><name><surname>Van Herle</surname><given-names>A</given-names></name><etal/><article-title>Brain glucose metabolism in hypothyroidism: a positron emission tomography study before and after thyroid hormone replacement therapy</article-title><source>J Clin Endocrinol Metab</source><year>2009</year><volume>94</volume><fpage>2922</fpage><lpage>2929</lpage><pub-id pub-id-type="doi">10.1210/jc.2008-2235</pub-id><pub-id pub-id-type="pmid">19435829</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Baumgartner</surname><given-names>A</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Hellweg</surname><given-names>R</given-names></name><article-title>Treatment of Intractable Non-Rapid Cycling Bipolar Affective-Disorder with High-Dose Thyroxine - An Open Clinical-Trial</article-title><source>Neuropsychopharmacology</source><year>1994</year><volume>10</volume><fpage>183</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">7916915</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="other"><name><surname>Kobiella</surname><given-names>A</given-names></name><name><surname>Smolka</surname><given-names>M</given-names></name><article-title>Neuroimaging of nicotine and tobacco smoking in humans</article-title><source>Encyclopedia of Addictive Behaviours</source><year>2011</year><comment>Chapter 261</comment></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="other"><name><surname>Lechan</surname><given-names>RM</given-names></name><name><surname>Toni</surname><given-names>R</given-names></name><article-title>Thyroid hormones in neural tissue</article-title><year>2002</year></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Koenig</surname><given-names>RJ</given-names></name><article-title>Thyroid hormone receptor coactivators and corepressors</article-title><source>Thyroid</source><year>1998</year><volume>8</volume><fpage>703</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1089/thy.1998.8.703</pub-id><pub-id pub-id-type="pmid">9737367</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Yen</surname><given-names>PM</given-names></name><article-title>Physiological and molecular basis of thyroid hormone action</article-title><source>Physiological Reviews</source><year>2001</year><volume>81</volume><fpage>1097</fpage><lpage>1142</lpage><pub-id pub-id-type="pmid">11427693</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>London</surname><given-names>ED</given-names></name><name><surname>Silverman</surname><given-names>DH</given-names></name><name><surname>Rasgon</surname><given-names>N</given-names></name><name><surname>Kirchheiner</surname><given-names>J</given-names></name><name><surname>Whybrow</surname><given-names>PC</given-names></name><article-title>Thyroid, brain and mood modulation in affective disorder: insights from molecular research and functional brain imaging</article-title><source>Pharmacopsychiatry</source><year>2003</year><volume>36</volume><issue>Suppl 3</issue><fpage>S215</fpage><lpage>S221</lpage><pub-id pub-id-type="pmid">14677082</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Hiroi</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>HH</given-names></name><name><surname>Ying</surname><given-names>H</given-names></name><name><surname>Furuya</surname><given-names>F</given-names></name><name><surname>Huang</surname><given-names>ZH</given-names></name><name><surname>Simoncini</surname><given-names>T</given-names></name><name><surname>Noma</surname><given-names>K</given-names></name><name><surname>Ulek</surname><given-names>K</given-names></name><name><surname>Nguyen</surname><given-names>NH</given-names></name><name><surname>Scanlan</surname><given-names>TS</given-names></name><etal/><article-title>Rapid nongenomic actions of thyroid hormone</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>2006</year><volume>103</volume><fpage>14104</fpage><lpage>14109</lpage><pub-id pub-id-type="doi">10.1073/pnas.0601600103</pub-id><pub-id pub-id-type="pmid">16966610</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Baur</surname><given-names>H</given-names></name><name><surname>Berghofer</surname><given-names>A</given-names></name><name><surname>Strohle</surname><given-names>A</given-names></name><name><surname>Hellweg</surname><given-names>R</given-names></name><name><surname>Muller-Oerlinghausen</surname><given-names>B</given-names></name><name><surname>Baumgartner</surname><given-names>A</given-names></name><article-title>Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disorders</article-title><source>Journal of Affective Disorders</source><year>2002</year><volume>68</volume><fpage>285</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1016/S0165-0327(00)00363-3</pub-id><pub-id pub-id-type="pmid">12063156</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Whybrow</surname><given-names>PC</given-names></name><name><surname>Prange</surname><given-names>AJ</given-names></name><article-title>A Hypothesis of Thyroid-Catecholamine-Receptor Interaction - Its Relevance to Affective-Illness</article-title><source>Archives of General Psychiatry</source><year>1981</year><volume>38</volume><fpage>106</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">6257196</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Hennemann</surname><given-names>G</given-names></name><name><surname>Docter</surname><given-names>R</given-names></name><name><surname>Friesema</surname><given-names>ECH</given-names></name><name><surname>De Jong</surname><given-names>M</given-names></name><name><surname>Krenning</surname><given-names>EP</given-names></name><name><surname>Visser</surname><given-names>TJ</given-names></name><article-title>Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability</article-title><source>Endocrine Reviews</source><year>2001</year><volume>22</volume><fpage>451</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1210/er.22.4.451</pub-id><pub-id pub-id-type="pmid">11493579</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="book"><name><surname>Schreiber</surname><given-names>G</given-names></name><article-title>The evolutionary and integrative roles of transthyretin in thyroid hormone homeostasis</article-title><source>J Endocrinol</source><year>2002</year><volume>175</volume><issue>1</issue><fpage>61</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1677/joe.0.1750061</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Visser</surname><given-names>TJ</given-names></name><article-title>Thyroid hormone transporters</article-title><source>Hormone Research</source><year>2007</year><volume>68</volume><fpage>28</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">18174701</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Baqui</surname><given-names>M</given-names></name><name><surname>Botero</surname><given-names>D</given-names></name><name><surname>Gereben</surname><given-names>B</given-names></name><name><surname>Curcio</surname><given-names>C</given-names></name><name><surname>Harney</surname><given-names>JW</given-names></name><name><surname>Salvatore</surname><given-names>D</given-names></name><name><surname>Sorimachi</surname><given-names>K</given-names></name><name><surname>Larsen</surname><given-names>PR</given-names></name><name><surname>Bianco</surname><given-names>AC</given-names></name><article-title>Human type 3 iodothyronine selenodeiodinase is located in the plasma membrane and undergoes rapid internalization to endosomes</article-title><source>Journal of Biological Chemistry</source><year>2003</year><volume>278</volume><fpage>1206</fpage><lpage>1211</lpage><pub-id pub-id-type="doi">10.1074/jbc.M210266200</pub-id><pub-id pub-id-type="pmid">12419801</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Williams</surname><given-names>GR</given-names></name><article-title>Neurodevelopmental and neurophysiological actions of thyroid hormone</article-title><source>Journal of Neuroendocrinology</source><year>2008</year><volume>20</volume><fpage>784</fpage><lpage>794</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2826.2008.01733.x</pub-id><pub-id pub-id-type="pmid">18601701</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>London</surname><given-names>ED</given-names></name><name><surname>Rasgon</surname><given-names>N</given-names></name><name><surname>Berman</surname><given-names>SM</given-names></name><name><surname>Frye</surname><given-names>MA</given-names></name><name><surname>Altshuler</surname><given-names>LL</given-names></name><name><surname>Mandelkern</surname><given-names>MA</given-names></name><name><surname>Bramen</surname><given-names>J</given-names></name><name><surname>Voytek</surname><given-names>B</given-names></name><name><surname>Woods</surname><given-names>R</given-names></name><etal/><article-title>Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression</article-title><source>Mol Psychiatry</source><year>2005</year><volume>10</volume><fpage>456</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1038/sj.mp.4001647</pub-id><pub-id pub-id-type="pmid">15724143</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Marwaha</surname><given-names>J</given-names></name><name><surname>Prasad</surname><given-names>KN</given-names></name><article-title>Hypothyroidism Elicits Electro-Physiological Noradrenergic Subsensitivity in Rat Cerebellum</article-title><source>Science</source><year>1981</year><volume>214</volume><fpage>675</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1126/science.6270792</pub-id><pub-id pub-id-type="pmid">6270792</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Surks</surname><given-names>MI</given-names></name><name><surname>Ortiz</surname><given-names>E</given-names></name><name><surname>Daniels</surname><given-names>GH</given-names></name><name><surname>Sawin</surname><given-names>CT</given-names></name><name><surname>Col</surname><given-names>NF</given-names></name><name><surname>Cobin</surname><given-names>RH</given-names></name><name><surname>Franklyn</surname><given-names>JA</given-names></name><name><surname>Hershman</surname><given-names>JM</given-names></name><name><surname>Burman</surname><given-names>KD</given-names></name><name><surname>Denke</surname><given-names>MA</given-names></name><etal/><article-title>Subclinical thyroid disease - Scientific review and guidelines for diagnosis and management</article-title><source>JAMA</source><year>2004</year><volume>291</volume><issue>2</issue><fpage>228</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1001/jama.291.2.228</pub-id><pub-id pub-id-type="pmid">14722150</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Joffe</surname><given-names>RT</given-names></name><name><surname>Marriott</surname><given-names>M</given-names></name><article-title>Thyroid hormone levels and recurrence of major depression</article-title><source>American Journal of Psychiatry</source><year>2000</year><volume>157</volume><fpage>1689</fpage><lpage>1691</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.157.10.1689</pub-id><pub-id pub-id-type="pmid">11007728</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Ruizmarcos</surname><given-names>A</given-names></name><name><surname>Sancheztoscano</surname><given-names>F</given-names></name><name><surname>Obregon</surname><given-names>MJ</given-names></name><name><surname>Delrey</surname><given-names>FE</given-names></name><name><surname>Deescobar</surname><given-names>GM</given-names></name><article-title>Thyroxine Treatment and Recovery of Hypothyroidism-Induced Pyramidal Cell-Damage</article-title><source>Brain Research</source><year>1982</year><volume>239</volume><fpage>559</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(82)90530-3</pub-id><pub-id pub-id-type="pmid">7093702</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Madeira</surname><given-names>MD</given-names></name><name><surname>Azevedo</surname><given-names>FP</given-names></name><name><surname>Paula-Barbosa</surname><given-names>MM</given-names></name><article-title>Effects of long-term hypothyroidism in the morphology and synaptic organization of cerebellar ectopic granule cells</article-title><source>Histol Histopathol</source><year>1988</year><volume>3</volume><fpage>351</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">2980244</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Ambrogini</surname><given-names>P</given-names></name><name><surname>Cuppini</surname><given-names>R</given-names></name><name><surname>Ferri</surname><given-names>P</given-names></name><name><surname>Mancini</surname><given-names>C</given-names></name><name><surname>Ciaroni</surname><given-names>S</given-names></name><name><surname>Voci</surname><given-names>A</given-names></name><name><surname>Gerdoni</surname><given-names>E</given-names></name><name><surname>Gallo</surname><given-names>G</given-names></name><article-title>Thyroid hormones affect neurogenesis in the dentate gyrus of adult rat</article-title><source>Neuroendocrinology</source><year>2005</year><volume>81</volume><fpage>244</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1159/000087648</pub-id><pub-id pub-id-type="pmid">16113586</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><name><surname>Madeira</surname><given-names>MD</given-names></name><name><surname>Cadete-Leite</surname><given-names>A</given-names></name><name><surname>Andrade</surname><given-names>JP</given-names></name><name><surname>Paula-Barbosa</surname><given-names>MM</given-names></name><article-title>Effects of hypothyroidism upon the granular layer of the dentate gyrus in male and female adult rats: a morphometric study</article-title><source>J Comp Neurol</source><year>1991</year><volume>314</volume><fpage>171</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1002/cne.903140116</pub-id><pub-id pub-id-type="pmid">1797872</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><name><surname>Alva-Sanchez</surname><given-names>C</given-names></name><name><surname>Ortiz-Butron</surname><given-names>R</given-names></name><name><surname>Pacheco-Rosado</surname><given-names>J</given-names></name><article-title>Kainic acid does not affect CA3 hippocampal region pyramidal cells in hypothyroid rats</article-title><source>Brain Research Bulletin</source><year>2004</year><volume>63</volume><fpage>167</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1016/j.brainresbull.2004.02.002</pub-id><pub-id pub-id-type="pmid">15130707</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><name><surname>Alva-Sancheza</surname><given-names>C</given-names></name><name><surname>Sanchez-Huerta</surname><given-names>K</given-names></name><name><surname>Arroyo-Helquera</surname><given-names>O</given-names></name><name><surname>Anquiano</surname><given-names>B</given-names></name><name><surname>Aceves</surname><given-names>C</given-names></name><name><surname>Pacheco-Rosado</surname><given-names>J</given-names></name><article-title>The maintenance of hippocampal pyramidal neuron populations is dependent on the modulation of specific cell cycle regulators by thyroid hormones</article-title><source>Brain Research</source><year>2009</year><volume>1271</volume><fpage>27</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">19269280</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><name><surname>Panagiotakos</surname><given-names>G</given-names></name><name><surname>Alshamy</surname><given-names>G</given-names></name><name><surname>Chan</surname><given-names>B</given-names></name><name><surname>Abrams</surname><given-names>R</given-names></name><name><surname>Greenberg</surname><given-names>E</given-names></name><name><surname>Saxena</surname><given-names>A</given-names></name><name><surname>Bradbury</surname><given-names>M</given-names></name><name><surname>Edgar</surname><given-names>M</given-names></name><name><surname>Gutin</surname><given-names>P</given-names></name><name><surname>Tabar</surname><given-names>V</given-names></name><article-title>Long-Term Impact of Radiation on the Stem Cell and Oligodendrocyte Precursors in the Brain</article-title><source>PLoS One</source><year>2007</year><volume>2</volume><issue>7</issue><fpage>e588</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0000588</pub-id><pub-id pub-id-type="pmid">17622341</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><name><surname>Venero</surname><given-names>C</given-names></name><name><surname>Guadano-Ferraz</surname><given-names>A</given-names></name><name><surname>Herrero</surname><given-names>AI</given-names></name><name><surname>Nordstrom</surname><given-names>K</given-names></name><name><surname>Manzano</surname><given-names>J</given-names></name><name><surname>de Escobar</surname><given-names>GM</given-names></name><name><surname>Bernal</surname><given-names>J</given-names></name><name><surname>Vennstrom</surname><given-names>B</given-names></name><article-title>Anxiety, memory impairment, and locomotor dysfunction caused by a mutant thyroid hormone receptor alpha 1 can be ameliorated by T3 treatment</article-title><source>Genes &#x00026; Development</source><year>2005</year><volume>19</volume><fpage>2152</fpage><lpage>2163</lpage><pub-id pub-id-type="doi">10.1101/gad.346105</pub-id><pub-id pub-id-type="pmid">16131613</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><name><surname>Pilhatsch</surname><given-names>M</given-names></name><name><surname>Winter</surname><given-names>C</given-names></name><name><surname>Nordstr&#x000f6;m</surname><given-names>K</given-names></name><name><surname>Vennstr&#x000f6;m</surname><given-names>B</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Juckel</surname><given-names>G</given-names></name><article-title>Increased depressive behaviour in mice harboring the mutant thyroid receptor alpha 1</article-title><source>Behav Brain Res</source><year>2010</year><volume>214</volume><issue>2</issue><fpage>187</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/j.bbr.2010.05.016</pub-id><pub-id pub-id-type="pmid">20580649</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><name><surname>Madeira</surname><given-names>MD</given-names></name><name><surname>Sousa</surname><given-names>N</given-names></name><name><surname>Lima-Andrade</surname><given-names>MT</given-names></name><name><surname>Calheiros</surname><given-names>F</given-names></name><name><surname>Cadete-Leite</surname><given-names>A</given-names></name><name><surname>Paula-Barbosa</surname><given-names>MM</given-names></name><article-title>Selective vulnerability of the hippocampal pyramidal neurons to hypothyroidism in male and female rats</article-title><source>J Comp Neurol</source><year>1992</year><volume>322</volume><fpage>501</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1002/cne.903220405</pub-id><pub-id pub-id-type="pmid">1401246</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><name><surname>Hasegawa</surname><given-names>M</given-names></name><name><surname>Kida</surname><given-names>I</given-names></name><name><surname>Wada</surname><given-names>H</given-names></name><article-title>A volumetric analysis of the brain and hippocampus of rats rendered perinatal hypothyroid</article-title><source>Neuroscience Letters</source><year>2010</year><volume>479</volume><fpage>240</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2010.05.070</pub-id><pub-id pub-id-type="pmid">20641164</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><name><surname>Baas</surname><given-names>D</given-names></name><name><surname>Legrand</surname><given-names>C</given-names></name><name><surname>Samarut</surname><given-names>J</given-names></name><name><surname>Flamant</surname><given-names>F</given-names></name><article-title>Persistence of oligodendrocyte precursor cells and altered myelination in optic nerve associated to retina degeneration in mice devoid of all thyroid hormone receptors</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>2002</year><volume>99</volume><fpage>2907</fpage><lpage>2911</lpage><pub-id pub-id-type="doi">10.1073/pnas.052482299</pub-id><pub-id pub-id-type="pmid">11867729</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><name><surname>Harsan</surname><given-names>LA</given-names></name><name><surname>Steibel</surname><given-names>J</given-names></name><name><surname>Zaremba</surname><given-names>A</given-names></name><name><surname>Agin</surname><given-names>A</given-names></name><name><surname>Sapin</surname><given-names>R</given-names></name><name><surname>Poulet</surname><given-names>P</given-names></name><name><surname>Guignard</surname><given-names>B</given-names></name><name><surname>Parizel</surname><given-names>N</given-names></name><name><surname>Grucker</surname><given-names>D</given-names></name><name><surname>Boehm</surname><given-names>N</given-names></name><etal/><article-title>Recovery from Chronic Demyelination by Thyroid Hormone Therapy: Myelinogenesis Induction and Assessment by Diffusion Tensor Magnetic Resonance Imaging</article-title><source>Journal of Neuroscience</source><year>2008</year><volume>28</volume><fpage>14189</fpage><lpage>14201</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4453-08.2008</pub-id><pub-id pub-id-type="pmid">19109501</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><name><surname>Fernandez</surname><given-names>M</given-names></name><name><surname>Giuliani</surname><given-names>A</given-names></name><name><surname>Pirondi</surname><given-names>S</given-names></name><name><surname>D'Intino</surname><given-names>G</given-names></name><name><surname>Giardino</surname><given-names>L</given-names></name><name><surname>Aloe</surname><given-names>L</given-names></name><name><surname>Levi-Montalcini</surname><given-names>R</given-names></name><name><surname>Calza</surname><given-names>L</given-names></name><article-title>Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>2004</year><volume>101</volume><fpage>16363</fpage><lpage>16368</lpage><pub-id pub-id-type="doi">10.1073/pnas.0407262101</pub-id><pub-id pub-id-type="pmid">15534218</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><name><surname>Franco</surname><given-names>PG</given-names></name><name><surname>Silvestroff</surname><given-names>L</given-names></name><name><surname>Soto</surname><given-names>EF</given-names></name><name><surname>Pasquini</surname><given-names>JM</given-names></name><article-title>Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination</article-title><source>Experimental Neurology</source><year>2008</year><volume>212</volume><fpage>458</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2008.04.039</pub-id><pub-id pub-id-type="pmid">18572165</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><name><surname>Franklin</surname><given-names>RJM</given-names></name><name><surname>Gilson</surname><given-names>JM</given-names></name><article-title>Remyelination in the CNS of the hypothyroid rat</article-title><source>Neuroreport</source><year>1996</year><volume>7</volume><fpage>1526</fpage><lpage>1530</lpage><pub-id pub-id-type="doi">10.1097/00001756-199606170-00018</pub-id><pub-id pub-id-type="pmid">8856713</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><name><surname>Jagannathan</surname><given-names>NR</given-names></name><name><surname>Tandon</surname><given-names>N</given-names></name><name><surname>Raghunathan</surname><given-names>P</given-names></name><name><surname>Kochupillai</surname><given-names>N</given-names></name><article-title>Reversal of abnormalities of myelination by thyroxine therapy in congenital hypothyroidism: localized in vivo proton magnetic resonance spectroscopy (MRS) study</article-title><source>Developmental Brain Research</source><year>1998</year><volume>109</volume><fpage>179</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/S0165-3806(98)00081-9</pub-id><pub-id pub-id-type="pmid">9729372</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><name><surname>Sijens</surname><given-names>PE</given-names></name><name><surname>Rodiger</surname><given-names>LA</given-names></name><name><surname>Meiners</surname><given-names>LC</given-names></name><name><surname>Lunsing</surname><given-names>RJ</given-names></name><article-title>H-1 magnetic resonance spectroscopy in monocarboxylate transporter 8 gene deficiency</article-title><source>Journal of Clinical Endocrinology &#x00026; Metabolism</source><year>2008</year><volume>93</volume><fpage>1854</fpage><pub-id pub-id-type="doi">10.1210/jc.2007-2441</pub-id><pub-id pub-id-type="pmid">18319316</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><name><surname>Basser</surname><given-names>PJ</given-names></name><name><surname>Jones</surname><given-names>DK</given-names></name><article-title>Diffusion-tensor MRI: theory, experimental design and data analy</article-title><source>NMR Biomed</source><year>2002</year><volume>15</volume><fpage>456</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1002/nbm.783</pub-id><pub-id pub-id-type="pmid">12489095</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><name><surname>Ashburner</surname><given-names>J</given-names></name><name><surname>Friston</surname><given-names>KJ</given-names></name><article-title>Voxel-based morphometry--the methods</article-title><source>Neuroimage</source><year>2000</year><volume>11</volume><fpage>805</fpage><lpage>821</lpage><pub-id pub-id-type="doi">10.1006/nimg.2000.0582</pub-id><pub-id pub-id-type="pmid">10860804</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><name><surname>Fischl</surname><given-names>B</given-names></name><name><surname>Dale</surname><given-names>AM</given-names></name><article-title>Measuring the thickness of the human cerebral cortex from magnetic resonance images</article-title><source>Proc Natl Acad Sci U S A</source><year>2000</year><volume>97</volume><fpage>11050</fpage><lpage>11055</lpage><pub-id pub-id-type="pmid">10984517</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><name><surname>Hutton</surname><given-names>C</given-names></name><name><surname>De Vita</surname><given-names>E</given-names></name><name><surname>Ashburner</surname><given-names>J</given-names></name><name><surname>Deichmann</surname><given-names>R</given-names></name><name><surname>Turner</surname><given-names>R</given-names></name><article-title>Voxel-based cortical thickness measurements in MRI</article-title><source>Neuroimage</source><year>2008</year><volume>40</volume><fpage>1701</fpage><lpage>1710</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2008.01.027</pub-id><pub-id pub-id-type="pmid">18325790</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><name><surname>Lass</surname><given-names>P</given-names></name><name><surname>Slawek</surname><given-names>J</given-names></name><name><surname>Derejko</surname><given-names>A</given-names></name><name><surname>Rubello</surname><given-names>D</given-names></name><article-title>Neurological and psychiatric disorders in thyroid dysfunctions. The role of nuclear medicine: SPECT and PET imaging</article-title><source>Minerva Endocrinologica</source><year>2008</year><volume>33</volume><fpage>75</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">18388853</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><name><surname>Napoli</surname><given-names>R</given-names></name><name><surname>Apuzzi</surname><given-names>V</given-names></name><name><surname>Bosso</surname><given-names>G</given-names></name><name><surname>D'Anna</surname><given-names>C</given-names></name><name><surname>De Sena</surname><given-names>A</given-names></name><name><surname>Pirozzi</surname><given-names>C</given-names></name><name><surname>Marano</surname><given-names>A</given-names></name><name><surname>Lupoli</surname><given-names>GA</given-names></name><name><surname>Cudemo</surname><given-names>G</given-names></name><name><surname>Oliviero</surname><given-names>U</given-names></name><etal/><article-title>Recombinant Human Thyrotropin Enhances Endothelial-Mediated Vasodilation of Conduit Arteries</article-title><source>Journal of Clinical Endocrinology &#x00026; Metabolism</source><year>2009</year><volume>94</volume><fpage>1012</fpage><lpage>1016</lpage><pub-id pub-id-type="pmid">19106266</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><name><surname>Erikci</surname><given-names>AA</given-names></name><name><surname>Karagoz</surname><given-names>B</given-names></name><name><surname>Ozturk</surname><given-names>A</given-names></name><name><surname>Caglayan</surname><given-names>S</given-names></name><name><surname>Ozisik</surname><given-names>G</given-names></name><name><surname>Kaygusuz</surname><given-names>I</given-names></name><name><surname>Ozata</surname><given-names>M</given-names></name><article-title>The effect of subclinical hypothyroidism on platelet parameters</article-title><source>Hematology</source><year>2009</year><volume>14</volume><fpage>115</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1179/102453309X385124</pub-id><pub-id pub-id-type="pmid">19298725</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><name><surname>Schlenker</surname><given-names>EH</given-names></name><name><surname>Hora</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Redetzke</surname><given-names>RA</given-names></name><name><surname>Morkin</surname><given-names>E</given-names></name><name><surname>Gerdes</surname><given-names>AM</given-names></name><article-title>Effects of thyroidectomy, T-4, and DITPA replacement on brain blood vessel density in adult rats</article-title><source>American Journal of Physiology-Regulatory Integrative and Comparative Physiology</source><year>2008</year><volume>294</volume><fpage>R1504</fpage><lpage>R1509</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00027.2008</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><name><surname>Kinuya</surname><given-names>S</given-names></name><name><surname>Michigishi</surname><given-names>T</given-names></name><name><surname>Tonami</surname><given-names>N</given-names></name><name><surname>Aburano</surname><given-names>T</given-names></name><name><surname>Tsuji</surname><given-names>S</given-names></name><name><surname>Hashimoto</surname><given-names>T</given-names></name><article-title>Reversible cerebral hypoperfusion observed with Tc-99m HMPAO SPECT in reversible dementia caused by hypothyroidism</article-title><source>Clinical Nuclear Medicine</source><year>1999</year><volume>24</volume><fpage>666</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1097/00003072-199909000-00005</pub-id><pub-id pub-id-type="pmid">10478741</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><name><surname>Constant</surname><given-names>EL</given-names></name><name><surname>De Volder</surname><given-names>AG</given-names></name><name><surname>Ivanoiu</surname><given-names>A</given-names></name><name><surname>Bol</surname><given-names>A</given-names></name><name><surname>Labar</surname><given-names>D</given-names></name><name><surname>Seghers</surname><given-names>A</given-names></name><name><surname>Cosnard</surname><given-names>G</given-names></name><name><surname>Melin</surname><given-names>J</given-names></name><name><surname>Daumerie</surname><given-names>C</given-names></name><article-title>Cerebral blood flow and glucose metabolism in hypothyroidism: A positron emission tomography study</article-title><source>Journal of Clinical Endocrinology and Metabolism</source><year>2001</year><volume>86</volume><fpage>3864</fpage><lpage>3870</lpage><pub-id pub-id-type="doi">10.1210/jc.86.8.3864</pub-id><pub-id pub-id-type="pmid">11502825</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><name><surname>Krausz</surname><given-names>Y</given-names></name><name><surname>Freedman</surname><given-names>N</given-names></name><name><surname>Lester</surname><given-names>H</given-names></name><name><surname>Newman</surname><given-names>JP</given-names></name><name><surname>Barkai</surname><given-names>G</given-names></name><name><surname>Bocher</surname><given-names>M</given-names></name><name><surname>Chisin</surname><given-names>R</given-names></name><name><surname>Bonne</surname><given-names>O</given-names></name><article-title>Regional cerebral blood flow in patients with mild hypothyroidism</article-title><source>Journal of Nuclear Medicine</source><year>2004</year><volume>45</volume><fpage>1712</fpage><lpage>1715</lpage><pub-id pub-id-type="pmid">15471838</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><name><surname>Nagamachi</surname><given-names>S</given-names></name><name><surname>Jinnouchi</surname><given-names>S</given-names></name><name><surname>Nishii</surname><given-names>R</given-names></name><name><surname>Ishida</surname><given-names>Y</given-names></name><name><surname>Fujita</surname><given-names>S</given-names></name><name><surname>Futami</surname><given-names>S</given-names></name><name><surname>Kodama</surname><given-names>T</given-names></name><name><surname>Tamura</surname><given-names>S</given-names></name><name><surname>Kawai</surname><given-names>K</given-names></name><article-title>Cerebral blood flow abnormalities induced by transient hypothyroidism after thyroidectomy--analysis by tc-99m-HMPAO and SPM96</article-title><source>Ann Nucl Med</source><year>2004</year><volume>18</volume><fpage>469</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1007/BF02984562</pub-id><pub-id pub-id-type="pmid">15515745</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><name><surname>Krausz</surname><given-names>Y</given-names></name><name><surname>Freedman</surname><given-names>N</given-names></name><name><surname>Lester</surname><given-names>H</given-names></name><name><surname>Barkai</surname><given-names>G</given-names></name><name><surname>Levin</surname><given-names>T</given-names></name><name><surname>Bocher</surname><given-names>M</given-names></name><name><surname>Chisin</surname><given-names>R</given-names></name><name><surname>Lerer</surname><given-names>B</given-names></name><name><surname>Bonne</surname><given-names>O</given-names></name><article-title>Brain SPECT study of common ground between hypothyroidism and depression</article-title><source>International Journal of Neuropsychopharmacology</source><year>2007</year><volume>10</volume><fpage>99</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1017/S1461145706006481</pub-id><pub-id pub-id-type="pmid">16674833</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><name><surname>Forchetti</surname><given-names>CM</given-names></name><name><surname>Katsamakis</surname><given-names>G</given-names></name><name><surname>Garron</surname><given-names>DC</given-names></name><article-title>Autoimmune thyroiditis and a rapidly progressive dementia: Global hypoperfusion on SPECT scanning suggests a possible mechanism</article-title><source>Neurology</source><year>1997</year><volume>49</volume><fpage>623</fpage><lpage>629</lpage><pub-id pub-id-type="pmid">9270613</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><name><surname>Zhu</surname><given-names>DF</given-names></name><name><surname>Wang</surname><given-names>ZX</given-names></name><name><surname>Zhang</surname><given-names>DR</given-names></name><name><surname>Zhuang</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>JN</given-names></name><article-title>The effects of subclinical hypothyroidism on working memory: An FMRI study</article-title><source>Brain</source><year>2006</year><volume>192</volume><issue>11</issue><fpage>2923</fpage><lpage>2930</lpage><pub-id pub-id-type="pmid">16921178</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><name><surname>Marangell</surname><given-names>LB</given-names></name><name><surname>Ketter</surname><given-names>TA</given-names></name><name><surname>George</surname><given-names>MS</given-names></name><name><surname>Pazzaglia</surname><given-names>PJ</given-names></name><name><surname>Callahan</surname><given-names>AM</given-names></name><name><surname>Parekh</surname><given-names>P</given-names></name><name><surname>Andreason</surname><given-names>PJ</given-names></name><name><surname>Horwitz</surname><given-names>B</given-names></name><name><surname>Herscovitch</surname><given-names>P</given-names></name><name><surname>Post</surname><given-names>RM</given-names></name><article-title>Inverse relationship of peripheral thyrotropin-stimulating hormone levels to brain activity in mood disorders</article-title><source>American Journal of Psychiatry</source><year>1997</year><volume>154</volume><fpage>224</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">9016272</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><name><surname>Crisanti</surname><given-names>P</given-names></name><name><surname>Omri</surname><given-names>B</given-names></name><name><surname>Hughes</surname><given-names>EJ</given-names></name><name><surname>Meduri</surname><given-names>G</given-names></name><name><surname>Hery</surname><given-names>C</given-names></name><name><surname>Clauser</surname><given-names>E</given-names></name><name><surname>Jacquemin</surname><given-names>C</given-names></name><name><surname>Saunier</surname><given-names>B</given-names></name><article-title>The expression of thyrotropin receptor in the brain</article-title><source>Endocrinology</source><year>2001</year><volume>142</volume><fpage>812</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1210/en.142.2.812</pub-id><pub-id pub-id-type="pmid">11159854</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="other"><name><surname>Whybrow</surname><given-names>P</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><article-title>Behavioural and psychiatric aspects of hypothyroidism</article-title><year>2005</year></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><name><surname>Haupt</surname><given-names>M</given-names></name><name><surname>Kurz</surname><given-names>A</given-names></name><article-title>Reversibility of Dementia in Hypothyroidism</article-title><source>Journal of Neurology</source><year>1993</year><volume>240</volume><fpage>333</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1007/BF00839962</pub-id><pub-id pub-id-type="pmid">8336171</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><name><surname>Burmeister</surname><given-names>LA</given-names></name><name><surname>Ganguli</surname><given-names>M</given-names></name><name><surname>Dodge</surname><given-names>HH</given-names></name><name><surname>Toczek</surname><given-names>T</given-names></name><name><surname>DeKosky</surname><given-names>ST</given-names></name><name><surname>Nebes</surname><given-names>RD</given-names></name><article-title>Hypothyroidism and cognition: Preliminary evidence for a specific defect in memory</article-title><source>Thyroid</source><year>2001</year><volume>11</volume><fpage>1177</fpage><lpage>1185</lpage><pub-id pub-id-type="doi">10.1089/10507250152741037</pub-id><pub-id pub-id-type="pmid">12186506</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><name><surname>Haggerty</surname><given-names>JJ</given-names></name><name><surname>Prange</surname><given-names>AJ</given-names></name><article-title>Borderline Hypothyroidism and Depression</article-title><source>Annual Review of Medicine</source><year>1995</year><volume>46</volume><fpage>37</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1146/annurev.med.46.1.37</pub-id><pub-id pub-id-type="pmid">7598471</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><name><surname>Osterweil</surname><given-names>D</given-names></name><name><surname>Syndulko</surname><given-names>K</given-names></name><name><surname>Cohen</surname><given-names>SN</given-names></name><name><surname>Pettlerjennings</surname><given-names>PD</given-names></name><name><surname>Hershman</surname><given-names>JM</given-names></name><name><surname>Cummings</surname><given-names>JL</given-names></name><name><surname>Tourtellotte</surname><given-names>WW</given-names></name><name><surname>Solomon</surname><given-names>DH</given-names></name><article-title>Cognitive Function in Nondemented Older Adults with Hypothyroidism</article-title><source>Journal of the American Geriatrics Society</source><year>1992</year><volume>40</volume><fpage>325</fpage><lpage>335</lpage><pub-id pub-id-type="pmid">1556359</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><name><surname>Miller</surname><given-names>K</given-names></name><name><surname>Parsons</surname><given-names>T</given-names></name><name><surname>Rasgon</surname><given-names>N</given-names></name><name><surname>Van Herle</surname><given-names>K</given-names></name><name><surname>Whybrow</surname><given-names>P</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><article-title>Hypothyroidism and specific memory deficits</article-title><source>Archives of Clinical Neuropsychology</source><year>2003</year><volume>18</volume><fpage>729</fpage><lpage>730</lpage></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><name><surname>Monzani</surname><given-names>F</given-names></name><name><surname>Delguerra</surname><given-names>P</given-names></name><name><surname>Caraccio</surname><given-names>N</given-names></name><name><surname>Pruneti</surname><given-names>CA</given-names></name><name><surname>Pucci</surname><given-names>E</given-names></name><name><surname>Luisi</surname><given-names>M</given-names></name><name><surname>Baschieri</surname><given-names>L</given-names></name><article-title>Subclinical Hypothyroidism - Neurobehavioral Features and Beneficial Effect of L-Thyroxine Treatment</article-title><source>Clinical Investigator</source><year>1993</year><volume>71</volume><fpage>367</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">8508006</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><name><surname>Baldini</surname><given-names>IM</given-names></name><name><surname>Vita</surname><given-names>A</given-names></name><name><surname>Mauri</surname><given-names>MC</given-names></name><name><surname>Amodei</surname><given-names>V</given-names></name><name><surname>Carrisi</surname><given-names>M</given-names></name><name><surname>Bravin</surname><given-names>S</given-names></name><name><surname>Cantalamessa</surname><given-names>L</given-names></name><article-title>Psychopathological and cognitive features in subclinical hypothyroidism</article-title><source>Progress in Neuro-Psychopharmacology &#x00026; Biological Psychiatry</source><year>1997</year><volume>21</volume><fpage>925</fpage><lpage>935</lpage><pub-id pub-id-type="doi">10.1016/S0278-5846(97)00089-4</pub-id><pub-id pub-id-type="pmid">9380789</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><name><surname>Gussekloo</surname><given-names>J</given-names></name><name><surname>van Exel</surname><given-names>E</given-names></name><name><surname>de Craen</surname><given-names>AJM</given-names></name><name><surname>Meinders</surname><given-names>AE</given-names></name><name><surname>Frolich</surname><given-names>M</given-names></name><name><surname>Westendorp</surname><given-names>RGJ</given-names></name><article-title>Thyroid status, disability and cognitive function, and survival in old age</article-title><source>JAMA</source><year>2004</year><volume>292</volume><issue>21</issue><fpage>2591</fpage><lpage>2599</lpage><pub-id pub-id-type="doi">10.1001/jama.292.21.2591</pub-id><pub-id pub-id-type="pmid">15572717</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><name><surname>Jorde</surname><given-names>R</given-names></name><name><surname>Waterloo</surname><given-names>K</given-names></name><name><surname>Storhaug</surname><given-names>H</given-names></name><name><surname>Nyrnes</surname><given-names>A</given-names></name><name><surname>Sundsfjord</surname><given-names>J</given-names></name><name><surname>Jenssen</surname><given-names>TG</given-names></name><article-title>Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment</article-title><source>Journal of Clinical Endocrinology &#x00026; Metabolism</source><year>2006</year><volume>91</volume><fpage>145</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1210/jc.2005-1775</pub-id><pub-id pub-id-type="pmid">16263815</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><name><surname>Maheu</surname><given-names>FS</given-names></name><name><surname>Mazzone</surname><given-names>L</given-names></name><name><surname>Merke</surname><given-names>DP</given-names></name><name><surname>Keil</surname><given-names>M</given-names></name><name><surname>Stratakis</surname><given-names>CA</given-names></name><name><surname>Pine</surname><given-names>DS</given-names></name><name><surname>Ernst</surname><given-names>M</given-names></name><article-title>Altered amygdala and hippocampus function in adolescents with hypercortisolemia: A functional magnetic resonance imaging study of Cushing syndrome</article-title><source>Development and Psychopathology</source><year>2008</year><volume>20</volume><fpage>1177</fpage><lpage>1189</lpage><pub-id pub-id-type="doi">10.1017/S0954579408000564</pub-id><pub-id pub-id-type="pmid">18838037</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><name><surname>Roberson-Nay</surname><given-names>R</given-names></name><name><surname>McClure</surname><given-names>EB</given-names></name><name><surname>Monk</surname><given-names>CS</given-names></name><name><surname>Nelson</surname><given-names>EE</given-names></name><name><surname>Guyer</surname><given-names>AE</given-names></name><name><surname>Fromm</surname><given-names>SJ</given-names></name><name><surname>Charney</surname><given-names>DS</given-names></name><name><surname>Leibenluft</surname><given-names>E</given-names></name><name><surname>Blair</surname><given-names>J</given-names></name><name><surname>Ernst</surname><given-names>M</given-names></name><name><surname>Pine</surname><given-names>DS</given-names></name><article-title>Increased amygdala activity during successful memory encoding in adolescent major depressive disorder: An FMRI study</article-title><source>Biol Psychiatry</source><year>2006</year><volume>60</volume><issue>9</issue><fpage>966</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2006.02.018</pub-id><pub-id pub-id-type="pmid">16603133</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><name><surname>Wolkowitz</surname><given-names>OM</given-names></name><name><surname>Burke</surname><given-names>H</given-names></name><name><surname>Epel</surname><given-names>ES</given-names></name><name><surname>Reus</surname><given-names>VL</given-names></name><article-title>Glucocorticoids. Mood, memory, and mechanisms</article-title><source>Ann N Y Acad Sci</source><year>2009</year><volume>1179</volume><fpage>19</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2009.04980.x</pub-id><pub-id pub-id-type="pmid">19906230</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><name><surname>Paiva</surname><given-names>FF</given-names></name><name><surname>Tannus</surname><given-names>A</given-names></name><name><surname>Silva</surname><given-names>AC</given-names></name><article-title>Measurement of cerebral perfusion territories using arterial spin labelling</article-title><source>Nmr in Biomedicine</source><year>2007</year><volume>20</volume><fpage>633</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1002/nbm.1177</pub-id><pub-id pub-id-type="pmid">17503440</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><name><surname>Barrett</surname><given-names>T</given-names></name><name><surname>Brechbiel</surname><given-names>M</given-names></name><name><surname>Bernardo</surname><given-names>M</given-names></name><name><surname>Choyke</surname><given-names>PL</given-names></name><article-title>MRI of tumor angiogenesis</article-title><source>Journal of Magnetic Resonance Imaging</source><year>2007</year><volume>26</volume><fpage>235</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1002/jmri.20991</pub-id><pub-id pub-id-type="pmid">17623889</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><name><surname>Laule</surname><given-names>C</given-names></name><name><surname>Vavasour</surname><given-names>IM</given-names></name><name><surname>Kolind</surname><given-names>SH</given-names></name><name><surname>Li</surname><given-names>DK</given-names></name><name><surname>Traboulsee</surname><given-names>TL</given-names></name><name><surname>Moore</surname><given-names>GR</given-names></name><name><surname>Mackay</surname><given-names>AL</given-names></name><article-title>Magnetic resonance imaging of myelin</article-title><source>Neurotherapeutics</source><year>2007</year><volume>4</volume><fpage>460</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1016/j.nurt.2007.05.004</pub-id><pub-id pub-id-type="pmid">17599712</pub-id></mixed-citation></ref></ref-list></back></article>